Department of Radiation Oncology, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, China.
Department of Respiratory, The Affiliated Xuzhou Municipal Hospital of Xuzhou Medical University, Xuzhou First People's Hospital, China.
Mol Oncol. 2020 Jun;14(6):1348-1364. doi: 10.1002/1878-0261.12691. Epub 2020 May 6.
High-mobility group protein B1 (HMGB1) has important functions in cancer cell proliferation and metastasis. However, the mechanisms of HMGB1 function in non-small-cell lung cancer (NSCLC) remain unclear. This study aimed to investigate the underlying mechanism of HMGB1-dependent tumor cell proliferation and NSCLC metastasis. Firstly, we found high HMGB1 expression in NSCLC and showed that HMBG1 promoted proliferation, migration, and invasion of NSCLC cells. HMGB1 could bind to SNAI1 promoter and activate the expression of SNAI1. In addition, HMGB1 could transcriptionally regulate the lncRNA RSF1-IT2. RSF1-IT2 was found to function as ceRNA, sponging miR-129-5p, which targets SNAI1. Notably, HMGB1 was also identified as a target of miR-129-5p, which indicates the establishment of a positive feedback loop. Consequently, high expression of RSF1-IT2 and SNAI1 was found to closely correlate with tumor progression in both HMGB1-overexpressing xenograft nude mice and patients with NSCLC. Taken together, our findings provide new insights into molecular mechanisms of HMGB1-dependent tumor metastasis. Components of the HMGB1-RSF1-IT2-miR-129-5p-SNAI1 pathway may have a potential as prognostic and therapeutic targets in NSCLC.
高迁移率族蛋白 B1(HMGB1)在癌细胞增殖和转移中具有重要功能。然而,HMGB1 在非小细胞肺癌(NSCLC)中的功能机制尚不清楚。本研究旨在探讨 HMGB1 依赖性肿瘤细胞增殖和 NSCLC 转移的潜在机制。首先,我们发现 NSCLC 中 HMGB1 表达较高,并表明 HMGB1 促进 NSCLC 细胞的增殖、迁移和侵袭。HMGB1 可以与 SNAI1 启动子结合并激活 SNAI1 的表达。此外,HMGB1 可以转录调节 lncRNA RSF1-IT2。发现 RSF1-IT2 作为 ceRNA,与 miR-129-5p 结合,后者靶向 SNAI1。值得注意的是,HMGB1 也是 miR-129-5p 的靶标,这表明建立了正反馈回路。因此,在 HMGB1 过表达的异种移植裸鼠和 NSCLC 患者中,发现 RSF1-IT2 和 SNAI1 的高表达与肿瘤进展密切相关。总之,我们的研究结果为 HMGB1 依赖性肿瘤转移的分子机制提供了新的见解。HMGB1-RSF1-IT2-miR-129-5p-SNAI1 通路的组成部分可能成为 NSCLC 的预后和治疗靶点。